Quality of Life Research in Pediatric Oncology. Research Methods and Barriers
Bradlyn, Andrew S.
Ritchey, A. Kim
Harris, Carole V.
Moore, Ida M.
O'Brien, Richard T.
Parsons, Susan K.
Pollock, Brad H.
Cancer 1996 September 15; 78(6): 1333-1339
Showing items related by title, author, creator and subject.
Holcomb, John B; Weiskopf, Richard; Champion, Howard; Gould, Steven A; Sauer, R Michelle; Brasel, Karen; Bochicchio, Grant; Bulger, Eileen; Cotton, Bryan A; Davis, Daniel; Dutton, Richard; Hauser, Carl J; Hess, John R; Hides, George A; Knudson, Paula; MacKenzie, Ellen; McGinnis, Robert L; Michalek, Joel; Moore, Frederick A; Omert, Laurel; Pollock, Brad H; Tortella, Bartholomew; Sugarman, Jeremy; Schreiber, Martin A; Wade, Charles E (2011-02)Selection of study endpoints is one of the most important decisions in the design of effective clinical trials. Late mortality (e.g., 28 days) is an unambiguous endpoint, accepted by regulatory agencies, but it is viewed ...
West, Charles; Pace, Nicholas; Niermeyer, Susan; Moore, Lorna Grindlay; Platt, M.P. Ward; Fleming, P.J.; Blair, P.S.; Leach, C.E.A.; Golding, J.; Smith, I.; Johnson, Paul; Savulescu, Julian; James, P.B.; Southall, David; Poets, C.; O'Brien, Louise; Stebbens, Valerie; Parkins, K. (1998-09-05)